# Testing the Safety and Efficacy of a Novel Barrier Cream for the Treatment of Moisture Associated Skin Damage

> **NCT06221046** · NA · NOT_YET_RECRUITING · sponsor: **Scotiaderm** · enrollment: 60 (estimated)

## Conditions studied

- Moisture Associated Skin Damage
- Incontinence Associated Dermatitis
- Fecal Incontinence

## Interventions

- **DRUG:** Control (Standard treatment)
- **OTHER:** Novel Barrier Cream

## Key facts

- **NCT ID:** NCT06221046
- **Lead sponsor:** Scotiaderm
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06221046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06221046, "Testing the Safety and Efficacy of a Novel Barrier Cream for the Treatment of Moisture Associated Skin Damage". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06221046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*